 BAUDETTE, Minn.--BUSINESS WIRE--ANI Pharmaceuticals, Inc. ANI or the Company NASDAQ: ANIP today announced business highlights and financial results for the three and nine months ended September 30, 2020. Business and Recent Highlights: Companys supplemental New Drug Application sNDA for lead product, Cortrophin Gel, re-filing on track; driving commercial and operational readiness for a successful launch; Welcomed Nikhil Lalwani as President and CEO, on September 8, 2020; and Broa 